Literature DB >> 11383230

Reactive hypoglycaemia due to late dumping syndrome: successful treatment with acarbose.

A Imhof1, M Schneemann, A Schaffner, M Brändle.   

Abstract

Reactive hypoglycaemia is a rare disease which occurs postprandially in everyday life involving blood glucose levels below 2.5 to 2.8 mmol/l. We report on a 66-year-old patient who developed symptomatic reactive hypoglycaemia due to late dumping syndrome 10 years after oesophagectomy with cervical anastomosis. A 75 g sucrose load revealed a plasma glucose level of 9.4 mmol/l after one hour, followed by symptomatic hypoglycaemia with a plasma glucose level of 1.8 mmol/l after three hours. Concomitantly, high concentrations of insulin (3216 pmol/l at a glucose level of 9.4 mmol/l and 335 pmol/l at a glucose level of 1.8 mmol/l) and glucagon-like peptide 1 (GLP-1) (375 pmol/l at a glucose level of 9.4 mmol/l and 85 pmol/l at a glucose level of 1.8 mmol/l) were measured. While the patient was under treatment with acarbose, another sucrose load did not provoke symptomatic hypoglycaemia (plasma glucose nadir of 4.6 mmol/l after two hours). Insulin and GLP-1 levels increased much less, to peak levels of 375 pmol/l and 75 pmol/l respectively, after one hour when plasma glucose was 6.8 mmol/l. We conclude that in patients with reactive hypoglycaemia due to gastrointestinal surgery, acarbose decreases rapid glucose absorption associated with hyperglycaemia and GLP-1 secretion, and thus diminishes excessive insulin release. Acarbose is therefore a successful treatment modality for reactive hypoglycaemia due to late dumping syndrome.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11383230     DOI: 2001/05/smw-09667

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN: 0036-7672            Impact factor:   2.193


  8 in total

1.  Acarbose improves hypoglycaemia following gastric bypass surgery without increasing glucagon-like peptide 1 levels.

Authors:  Juan Patricio Valderas; Jessica Ahuad; Lorena Rubio; Manuel Escalona; Felipe Pollak; Alberto Maiz
Journal:  Obes Surg       Date:  2012-04       Impact factor: 4.129

2.  Effect of steroid therapy for late dumping syndrome after total gastrectomy: report of a case.

Authors:  Chikashi Shibata; Yuji Funayama; Kouhei Fukushima; Ken-ichi Shiiba; Iwao Sasaki; Kei-ichi Itoi; Hiroo Naito
Journal:  Dig Dis Sci       Date:  2004-05       Impact factor: 3.199

Review 3.  Hypoglycemia After Gastric Bypass Surgery: Current Concepts and Controversies.

Authors:  Marzieh Salehi; Adrian Vella; Tracey McLaughlin; Mary-Elizabeth Patti
Journal:  J Clin Endocrinol Metab       Date:  2018-08-01       Impact factor: 5.958

4.  Endoluminal Revision (OverStitch (TM) , Apollo Endosurgery) of the Dilated Gastroenterostomy in Patients with Late Dumping Syndrome After Proximal Roux-en-Y Gastric Bypass.

Authors:  Christine Stier; Sonja Chiappetta
Journal:  Obes Surg       Date:  2016-08       Impact factor: 4.129

5.  Effect of the addition of sitagliptin and miglitol on insulin-treated type 2 diabetes.

Authors:  Miyako Kishimoto; Mitsuhiko Noda
Journal:  Diabetes Ther       Date:  2012-09-28       Impact factor: 2.945

6.  Dumping Syndrome.

Authors:  William L. Hasler
Journal:  Curr Treat Options Gastroenterol       Date:  2002-04

Review 7.  Hypoglycemia After Upper Gastrointestinal Surgery: Clinical Approach to Assessment, Diagnosis, and Treatment.

Authors:  Amanda Sheehan; Mary Elizabeth Patti
Journal:  Diabetes Metab Syndr Obes       Date:  2020-11-19       Impact factor: 3.168

Review 8.  Endocrine and metabolic complications after bariatric surgery.

Authors:  Anwar A Jammah
Journal:  Saudi J Gastroenterol       Date:  2015 Sep-Oct       Impact factor: 2.485

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.